Furthermore, studies have revealed that the expression of estrogen receptors as well as hyperinsulinemia-associated molecules including insulin, glucose, leptin, and IGF-1 was significantly decreased in EC patients after metformin therapy,[66–68] indicating an anti-proliferative effect on EC following treatment with metformin. The gene discussed is INS; the disease is hyperinsulinism.